Deal Type

Diaverum, a Sweden-born, multinational healthcare organisation providing life-enhancing renal care to patients with chronic kidney disease, is expanding in Germany with the acquisition of...

Healthcare Holding Schweiz, a distributor of medical devices and services across the Swiss healthcare landscape managed by multi-family investor Winterberg Advisory, has acquired Effectum CH-Rep. Through this acquisition,...

AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a Belgium-based biotech company pioneering in vivo cell therapies. The acquisition includes EsoBiotec’s Engineered NanoBody...

Asker Healthcare, a Sweden-based provider of medical products and solutions, has set the final price in its upcoming IPO at SEK70 per share, equivalent to...

Sofinnova Partners, a European life sciences venture capital firm based in Paris, London, and Milan, has held the final close of Sofinnova Biovelocita II,...

Sanoptis, a Switzerland-based European network of modern ophthalmology clinics, has secured a €250m (US$274m) capital increase in the form of preferred equity from US-based...

DocMorris, a Swiss online pharmacy and pharma wholesaling group, is evaluating various options for raising equity of around CHF200m (US$227m), to strengthen its balance...

Taiho Pharmaceutical, a subsidiary of Tokyo-listed Otsuka Holdings, is acquiring Switzerland-based Araris Biotech, a company developing next-generation antibody drug conjugates (ADCs). Under the terms of...

SIX-listed pure-play dermatology company, Galderma, has issued three bonds as part of its refinancing strategy to spread out its maturity profile, diversify funding sources...

DBay Advisor’s planned acquisition of listed UK consumer healthcare company Alliance Pharma has received the necessary shareholder approval. In January, the board of Alliance Pharma...